News about Global Pharma

Australia-headquartered Novotech to acquire EastHORN

Australia-headquartered Novotech to acquire EastHORN

The acquisition is part of Novotech's global expansion programme

Global Pharma | 17/01/2023 | By Sudeep Soparkar

Sai Life Sciences in agreement to set up Schrodinger's first dedicated offshore research lab in India

Sai Life Sciences in agreement to set up Schrodinger's first dedicated offshore research lab in India

The lab will be a dedicated facility for integrated discovery work streams including medicinal and synthetic chemistry, in vitro biology, and process chemistry

Global Pharma | 11/01/2023 | By Sudeep Soparkar

Taiwan-based PharmaEssentia Corporation plans PharmaEssentia Innovation Research Center in greater Boston, Massachusetts area

Taiwan-based PharmaEssentia Corporation plans PharmaEssentia Innovation Research Center in greater Boston, Massachusetts area

PIRC will be equipped with a state-of-the-art lab featuring cutting-edge technology to support the identification and development of therapeutic opportunities

Global Pharma | 09/01/2023 | By Sudeep Soparkar

Polysciences creates new bioprocessing brand, Kyfora Bio

Polysciences creates new bioprocessing brand, Kyfora Bio

Based in Horsham, PA, Kyfora Bio will occupy a 45,000 sq ft cGMP facility with administrative offices, R&D labs, manufacturing suites

Global Pharma | 03/01/2023 | By Sudeep Soparkar

Cipla EU in agreement with Ethris

Cipla EU in agreement with Ethris

To invest EUR 15 Million

Global Pharma | 30/12/2022 | By Sudeep Soparkar

Advent International to pick up 50.1% in Suven Pharma for Rs 6,313 Cr

Advent International to pick up 50.1% in Suven Pharma for Rs 6,313 Cr

The buyout is part of the private equity firm’s plan to create a contract drug manufacturing powerhouse in India

Global Pharma | 27/12/2022 | By Sudeep Soparkar

KBI Biopharma secures Swissmedic Regulatory Establishment License for Geneva facility

KBI Biopharma secures Swissmedic Regulatory Establishment License for Geneva facility

The license allows KBI to fully support clients in their next phases of growth and certifies KBI's manufacturing capabilities in a cGMP environment

Global Pharma | 26/12/2022 | By Sudeep Soparkar

Florida-based Formulated Solutions to buy Merck & Co and Bayer manufacturing facility

Florida-based Formulated Solutions to buy Merck & Co and Bayer manufacturing facility

The manufacturing facility is located in Cleveland, Tennessee

Global Pharma | 21/12/2022 | By Sudeep Soparkar 199

JB Pharma to acquire the entire Razel (Rosuvastatin) franchise for Rs. 314 crores

JB Pharma to acquire the entire Razel (Rosuvastatin) franchise for Rs. 314 crores

The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy. Razel ranks among the top 10 brands in the Rosuvastatin molecule category in the country <br />

Global Pharma | 15/12/2022 | By Sudeep Soparkar

Lupin appoints Spiro Gavaris as President of US generics biz

Lupin appoints Spiro Gavaris as President of US generics biz

Gavaris will be responsible for the overall strategy, implementation and growth of Lupin’s US Generics business

Global Pharma | 09/12/2022 | By Sudeep Soparkar

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology